Abstract
Dystrophin-deficient muscular dystrophy (Duchenne dystrophy) is characterized by impaired ion homeostasis, in which mitochondria play an important role. In the present work, using a model of dystrophin-deficient mdx mice, we revealed decrease in the efficiency of potassium ion transport and total content of this ion in the heart mitochondria. We evaluated the effect of chronic administration of the benzimidazole derivative NS1619, which is an activator of the large-conductance Ca2+-dependent K+ channel (mitoBKCa), on the structure and function of organelles and the state of the heart muscle. It was shown that NS1619 improves K+ transport and increases content of the ion in the heart mitochondria of mdx mice, but this is not associated with the changes in the level of mitoBKCa protein and expression of the gene encoding this protein. The effect of NS1619 was accompanied by the decrease in the intensity of oxidative stress, assessed by the level of lipid peroxidation products (MDA products), and normalization of the mitochondrial ultrastructure in the heart of mdx mice. In addition, we found positive changes in the tissue manifested by the decrease in the level of fibrosis in the heart of dystrophin-deficient animals treated with NS1619. It was noted that NS1619 had no significant effect on the structure and function of heart mitochondria in the wild-type animals. The paper discusses mechanisms of influence of NS1619 on the function of mouse heart mitochondria in Duchenne muscular dystrophy and prospects for applying this approach to correct pathology.
Abbreviations
- DMD:
-
Duchenne muscular dystrophy
- DNP:
-
2,4-dinitrophenol
- MDA:
-
malondialdehyde
- mitoBKCa :
-
Ca2+-activated mitochondrial potassium channel
- MPT pore:
-
mitochondrial permeability transition pore
- mtDNA:
-
mitochondrial DNA
- nDNA:
-
nuclear DNA
- ROS:
-
reactive oxygen species
References
Emery, A. E. (1991) Population frequencies of inherited neuromuscular diseases – A world survey, Neuromuscul. Disord., 1, 19-29, https://doi.org/10.1016/0960-8966(91)90039-u.
Mavrogeni, S., Markousis-Mavrogenis, G., Papavasiliou, A., and Kolovou, G. (2015) Cardiac involvement in Duchenne and Becker muscular dystrophy, World J. Cardiol., 7, 410-414, https://doi.org/10.4330/wjc.v7.i7.410.
Ignatieva, E., Smolina, N., Kostareva, A., and Dmitrieva, R. (2021) Skeletal muscle mitochondria dysfunction in genetic neuromuscular disorders with cardiac phenotype, Int. J. Mol. Sci., 22, 7349, https://doi.org/10.3390/ijms22147349.
Kamdar, F., and Garry, D. J. (2016) Dystrophin-deficient cardiomyopathy, J. Am. Coll. Cardiol., 67, 2533-2546, https://doi.org/10.1016/j.jacc.2016.02.081.
D’Amario, D., Amodeo, A., Adorisio, R., Tiziano, F. D., Leone, A. M., Perri, G., Bruno, P., Massetti, M., Ferlini, A., Pane, M., Niccoli, G., Porto, I., D’Angelo, G. A., Borovac, J. A., Mercuri, E., and Crea, F. (2017) A current approach to heart failure in Duchenne muscular dystrophy, Heart, 103, 1770-1779, https://doi.org/10.1136/heartjnl-2017-311269.
Ware, S. M. (2017) Genetics of paediatriccardiomyopathies, Curr. Opin. Pediatr., 29, 534-540, https://doi.org/10.1097/MOP.0000000000000533.
Angelini, G., Mura, G., and Messina, G. (2022) Therapeutic approaches to preserve the musculature in Duchenne muscular dystrophy: The importance of the secondary therapies, Exp. Cell Res., 410, 112968, https://doi.org/10.1016/j.yexcr.2021.112968.
Rybalka, E., Timpani, C., Cooke, M. B., Williams, A., and Hayes, A. (2014) Defects in mitochondrial ATP synthesis in dystrophin-deficient mdx skeletal muscles may be caused by complex I insufficiency, PLoS One, 9, e115763, https://doi.org/10.1371/journal.pone.0115763.
Vila, M. C., Rayavarapu, S., Hogarth, M., van der Meulen, J. H., Horn, A., Defour, A., Takeda, S., Brown, K. J., Hathout, Y., Nagaraju, K., and Jaiswal, J. K. (2017) Mitochondria mediate cell membrane repair and contribute to Duchenne muscular dystrophy, Cell Death Differ., 24, 330-342, https://doi.org/10.1038/cdd.2016.127.
Schiavone, M., Zulian, A., Menazza, S., Petronilli, V., Argenton, F., Merlini, L., Sabatelli, P., and Bernardi, P. (2017) Alisporivir rescues defective mitochondrial respiration in Duchenne muscular dystrophy, Pharmacol. Res., 125, 122-131, https://doi.org/10.1016/j.phrs.2017.09.001.
Hughes, M. C., Ramos, S. V., Turnbull, P. C., Rebalka, I. A., Cao, A., Monaco, C. M., Varah, N. E., Edgett, B. A., Huber, J. S., Tadi, P., Delfinis, L. J., Schlattner, U., Simpson, J. A., Hawke, T. J., and Perry, C. G. R. (2019) Early myopathy in Duchenne muscular dystrophy is associated with elevated mitochondrial H2O2 emission during impaired oxidative phosphorylation, J. Cachexia Sarcopenia Muscle, 10, 643-661, https://doi.org/10.1002/jcsm.12405.
Dubinin, M. V., Talanov, E. Y., Tenkov, K. S., Starinets, V. S., Mikheeva, I. B., Sharapov, M. G., and Belosludtsev, K. N. (2020) Duchenne muscular dystrophy is associated with the inhibition of calcium uniport in mitochondria and an increased sensitivity of the organelles to the calcium-induced permeability transition, Biochim. Biophys. Acta Mol. Basis Dis., 1866, 165674, https://doi.org/10.1016/j.bbadis.2020.165674.
Dubinin, M. V., Talanov, E. Y., Tenkov, K. S., Starinets, V. S., Belosludtseva, N. V., and Belosludtsev, K. N. (2020) The effect of deflazacort treatment on the functioning of skeletal muscle mitochondria in Duchenne muscular dystrophy, Int. J. Mol. Sci., 21, 8763, https://doi.org/10.3390/ijms21228763.
Mareedu, S., Million, E. D., Duan, D., and Babu, G. J. (2021) Abnormal calcium handling in Duchenne muscular dystrophy: mechanisms and potential therapies, Front. Physiol., 12, 647010, https://doi.org/10.3389/fphys.2021.647010.
Zhang, W., ten Hove, M., Schneider, J. E., Stuckey, D. J., Sebag-Montefiore, L., Bia, B. L., Radda, G. K., Davies, K. E., Neubauer, S., and Clarke, K. (2008) Abnormal cardiac morphology, function and energy metabolism in the dystrophic mdx mouse: An MRI and MRS study, J. Mol. Cell. Cardiol., 45, 754-760, https://doi.org/10.1016/j.yjmcc.2008.09.125.
Kyrychenko, V., Poláková, E., Janíček, R., and Shirokova, N. (2015) Mitochondrial dysfunctions during progression of dystrophic cardiomyopathy, Cell Calcium, 58, 186-195, https://doi.org/10.1016/j.ceca.2015.04.006.
Willi, L., Abramovich, I., Fernandez-Garcia, J., Agranovich, B., Shulman, M., Milman, H., Baskin, P., Eisen, B., Michele, D. E., Arad, M., Binah, O., and Gottlieb, E. (2022) Bioenergetic and metabolic impairments in induced pluripotent stem cell-derived cardiomyocytes generated from Duchenne muscular dystrophy patients, Int. J. Mol. Sci., 23, 9808, https://doi.org/10.3390/ijms23179808.
Ascah, A., Khairallah, M., Daussin, F., Bourcier-Lucas, C., Godin, R., Allen, B. G., Petrof, B. J., Rosiers, C. D., Burelle, Y. (2011) Stress-induced opening of the permeability transition pore in the dystrophin-deficient heart is attenuated by acute treatment with sildenafil, Am. J. Physiol. Heart Circ. Physiol., 300, H144-H153, https://doi.org/10.1152/ajpheart.00522.2010.
Dubinin, M. V., Talanov, E. Y., Tenkov, K. S., Starinets, V. S., Mikheeva, I. B., and Belosludtsev, K. N. (2020) Transport of Ca2+ and Ca2+-dependent permeability transition in heart mitochondria in the early stages of Duchenne muscular dystrophy, Biochim. Biophys. Acta Bioenerg., 1861, 148250, https://doi.org/10.1016/j.bbabio.2020.148250.
Angebault, C., Panel, M., Lacôte, M., Rieusset, J., Lacampagne, A., and Fauconnier, J. (2021) Metformin reverses the enhanced myocardial SR/ER-mitochondria interaction and impaired complex I-driven respiration in dystrophin-deficient mice, Front. Cell Dev. Biol., 8, 609493, https://doi.org/10.3389/fcell.2020.609493.
Dubinin, M. V., Starinets, V. S., Talanov, E. Y., Mikheeva, I. B., Belosludtseva, N. V., Serov, D. A., Tenkov, K. S., Belosludtseva, E. V., and Belosludtsev, K. N. (2021) Effect of the non-immunosuppressive MPT pore inhibitor alisporivir on the functioning of heart mitochondria in dystrophin-deficient mdx mice, Biomedicines, 9, 1232, https://doi.org/10.3390/biomedicines9091232.
Bienengraeber, M., Olson, T. M., Selivanov, V. A., Kathmann, E. C., O’Cochlain, F., Gao, F., Karger, A. B., Ballew, J. D., Hodgson, D. M., Zingman, L. V., Pang, Y. P., Alekseev, A. E., and Terzic, A. (2004) ABCC9 mutations identified in human dilated cardiomyopathy disrupt catalytic KATP channel gating, Nat. Genet., 36, 382-387, https://doi.org/10.1038/ng1329.
Farid, T. A., Nair, K., Massé, S., Azam, M. A., Maguy, A., Lai, R. F., Umapathy, K., Dorian, P., Chauhan, V., Varró, A., Al-Hesayen, A., Waxman, M., Nattel, S., and Nanthakumar, K. (2011) Role of KATP channels in the maintenance of ventricular fibrillation in cardiomyopathic human hearts, Circ. Res., 109, 1309-1318, https://doi.org/10.1161/CIRCRESAHA.110.232918.
Graciotti, L., Becker, J., Granata, A. L., Procopio, A. D., Tessarollo, L., and Fulgenzi, G. (2011) Dystrophin is required for the normal function of the cardio-protective K(ATP) channel in cardiomyocytes, PLoS One, 6, e27034, https://doi.org/10.1371/journal.pone.0027034.
Dubinin, M. V., Starinets, V. S., Belosludtseva, N. V., Mikheeva, I. B., Chelyadnikova, Y. A., Penkina, D. K., Vedernikov, A. A., and Belosludtsev, K. N. (2022) The effect of uridine on the state of skeletal muscles and the functioning of mitochondria in Duchenne dystrophy, Int. J. Mol. Sci., 23, 10660, https://doi.org/10.3390/ijms231810660.
Dubinin, M. V., Starinets, V. S., Belosludtseva, N. V., Mikheeva, I. B., Chelyadnikova, Y. A., Igoshkina, A. D., Vafina, A. B., Vedernikov, A. A., and Belosludtsev, K. N. (2022) BKCa activator NS1619 improves the structure and function of skeletal muscle mitochondria in Duchenne dystrophy, Pharmaceutics, 14, 2336, https://doi.org/10.3390/ijms231810660.
Checchetto, V., Leanza, L., De Stefani, D., Rizzuto, R., Gulbins, E., and Szabo, I. (2021) Mitochondrial K+ channels and their implications for disease mechanisms, Pharmacol. Ther., 227, 107874, https://doi.org/10.1016/j.pharmthera.2021.107874.
Zorov, D. B. (2022) A window to the potassium world. The evidence of potassium energetics in the mitochondria and identity of the mitochondrial ATP-dependent K+ channel, Biochemistry (Moscow), 87, 683-688, https://doi.org/10.1134/S0006297922080016.
Juhaszova, M., Kobrinsky, E., Zorov, D. B., Nuss, H. B., Yaniv, Y., Fishbein, K. W., de Cabo, R., Montoliu, L., Gabelli, S. B., Aon, M. A., Cortassa, S., and Sollott, S. J. (2021) ATP Synthase K+- and H+-fluxes drive ATP synthesis and enable mitochondrial K+-“Uniporter” function: I. Characterization of ion fluxes, Function (Oxf), 3, zqab065, https://doi.org/10.1093/function/zqab065.
Juhaszova, M., Kobrinsky, E., Zorov, D. B., Nuss, H. B., Yaniv, Y., Fishbein, K. W., de Cabo, R., Montoliu, L., Gabelli, S. B., Aon, M. A., Cortassa, S., and Sollott, S. J. (2022) ATP synthase K+- and H+-fluxes drive ATP synthesis and enable mitochondrial K+-“Uniporter” function: II. Ion and ATP synthase flux regulation, Function (Oxf), 3, zqac001, https://doi.org/10.1093/function/zqac001.
González-Sanabria, N., Echeverría, F., Segura, I., Alvarado-Sánchez, R., and Latorre, R. (2021) BK in double-membrane organelles: A biophysical, pharmacological, and functional survey, Front. Physiol., 12, 761474, https://doi.org/10.3389/fphys.2021.761474.
Wang, X., Yin, C., Xi, L., and Kukreja, R. C. (2004) Opening of Ca2+-activated K+ channels triggers early and delayed preconditioning against I/R injury independent of NOS in mice, Am. J. Physiol. Heart Circ. Physiol., 287, H2070-H2077, https://doi.org/10.1152/ajpheart.00431.2004.
Lam, J., Katti, P., Biete, M., Mungai, M., AshShareef, S., Neikirk, K., Garza Lopez, E., Vue, Z., Christensen, T. A., Beasley, H. K., Rodman, T. A., Murray, S. A., Salisbury, J. L., Glancy, B., Shao, J., Pereira, R. O., Abel, E. D., and Hinton, A. (2021) A universal approach to analyzing transmission electron microscopy with ImageJ, Cells, 10, 2177, https://doi.org/10.3390/cells10092177.
Bradford, M. M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding, Anal. Biochem., 72, 248-254, https://doi.org/10.1006/abio.1976.9999.
Dubinin, M. V., Semenova, A. A., Ilzorkina, A. I., Markelova, N. Y., Penkov, N. V., Shakurova, E. R., Belosludtsev, K. N., and Parfenova, L. V. (2021) New quaternized pyridinium derivatives of betulin: Synthesis and evaluation of membranotropic properties on liposomes, pro- and eukaryotic cells, and isolated mitochondria, Chem. Biol. Interact., 349, 109678, https://doi.org/10.1016/j.cbi.2021.109678.
Belosludtseva, N. V., Starinets, V. S., Pavlik, L. L., Mikheeva, I. B., Dubinin, M. V., and Belosludtsev, K. N. (2020) The effect of S-15176 difumarate salt on ultrastructure and functions of liver mitochondria of C57BL/6 mice with streptozotocin/high-fat diet-induced type 2 diabetes, Biology, 9, 309, https://doi.org/10.3390/biology9100309.
Ye, J., Coulouris, G., Zaretskaya, I., Cutcutache, I., Rozen, S., and Madden, T. L. (2012) Primer-BLAST: A tool to design target-specific primers for polymerase chain reaction, BMC Bioinform., 13, 134, https://doi.org/10.1186/1471-2105-13-134.
Schmittgen, T. D., and Livak, K. J. (2008) Analyzing real-time PCR data by the comparative CT method, Nat. Protoc., 3, 1101-1108, https://doi.org/10.1038/nprot.2008.73.
Quiros, P. M., Goyal, A., Jha, P., and Auwerx, J. (2017) Analysis of mtDNA/nDNA ratio in mice, Curr. Protoc. Mouse Biol., 7, 47-54, https://doi.org/10.1002/cpmo.21.
Szewczyk, A., Skalska, J., Głąb, M., Kulawiak, B., Malińska, D., Koszela-Piotrowska, I., and Kunz, W. S. (2006) Mitochondrial potassium channels: from pharmacology to function, Biochim. Biophys. Acta, 1757, 715-720, https://doi.org/10.1016/j.bbabio.2006.05.002.
Singh, H., Rong, L., Bopassa, J., Meredith, A., Stefani, E., and Toro, L. (2013) MitoBK-Ca is encoded by the KCNMA1 gene, and a splicing sequence defines its mitochondrial location, Proc. Natl. Acad. Sci. USA, 110, 10836-10841, https://doi.org/10.1073/pnas.1302028110.
Heinen, A., Aldakkak, M., Stowe, D. F., Rhodes, S. S., Riess, M. L., Varadarajan, S. G., and Camara, A. K. (2007) Reverse electron flow-induced ROS production is attenuated by activation of mitochondrial Ca2+-sensitive K+ channels, Am. J. Physiol. Heart Circ. Physiol., 293, H1400-H1407, https://doi.org/10.1152/ajpheart.00198.2007.
Kharraz, Y., Guerra, J., Pessina, P., Serrano, A. L., and Muñoz-Cánoves, P. (2014) Understanding the process of fibrosis in Duchenne muscular dystrophy, Biomed. Res. Int., 2014, 965631, https://doi.org/10.1155/2014/965631.
Wissing, E. R., Millay, D. P., Vuagniaux, G., and Molkentin, J. D. (2010) Debio-025 is more effective than prednisone in reducing muscular pathology in mdx mice, Neuromuscul. Disord., 20, 753-760, https://doi.org/10.1016/j.nmd.2010.06.016.
Dubinin, M. V., Starinets, V. S., Talanov, E. Y., Mikheeva, I. B., Belosludtseva, N. V., and Belosludtsev, K. N. (2021) Alisporivir Improves mitochondrial function in skeletal muscle of mdx mice but suppresses mitochondrial dynamics and biogenesis, Int. J. Mol. Sci., 22, 9780, https://doi.org/10.3390/ijms22189780.
Dai, H., Wang, M., Patel, P. N., Kalogeris, T., Liu, Y., Durante, W., and Korthuis, R. J. (2017) Preconditioning with the BKCa channel activator NS-1619 prevents ischemia-reperfusion-induced inflammation and mucosal barrier dysfunction: Roles for ROS and heme oxygenase-1, Am. J. Physiol. Heart Circ. Physiol., 313, H988-H999, https://doi.org/10.1152/ajpheart.00620.2016.
Li, Y., Zhang, S., Zhang, X., Li, J., Ai, X., Zhang, L., Yu, D., Ge, S., Peng, Y., and Chen, X. (2014) Blunted cardiac beta-adrenergic response as an early indication of cardiac dysfunction in Duchenne muscular dystrophy, Cardiovasc. Res., 103, 60-71, https://doi.org/10.1093/cvr/cvu119.
Acknowledgments
The authors acknowledge the Lomonosov Moscow State University development program (PNR 5.13) and Nikon center of Excellence at Belozersky Institute of Physico-Chemical Biology for providing access to the equipment and technical support.
Funding
This work was financially supported by the Russian Science Foundation (project no. 20-75-10006).
Author information
Authors and Affiliations
Contributions
M. V. Dubinin and K. N. Belosludtsev – conceived and supervised the study; M. V. Dubinin, V. S. Starinets, Yu. A. Chelyadnikova, N. V. Belosludtseva, I. B. Mikheeva, D. K. Penkina, A. D. Igoshkina, E. Yu. Talanov, I. I. Kireev – carried out experiments; M. V. Dubinin, K. N. Belosludtsev, D. B. Zorov – discussed the results of experiments with input from all authors; M. V. Dubinin – wrote the manuscript; M. V. Dubinin, K. N. Belosludtsev, D. B. Zorov – edited the manuscript.
Corresponding author
Ethics declarations
The authors declare no conflict of interest in financial or any other sphere. The work with laboratory animals was carried out in accordance with the European Convention for the Protection of Vertebrates used for experimental and other purposes (Strasbourg, 1986) and the principles of the Helsinki Declaration (2000). All mouse experimentation was approved by the Mari State University Ethics Committee (Protocol No. 01/2021 of 18 October 2021).
Electronic supplementary material
Rights and permissions
About this article
Cite this article
Dubinin, M.V., Starinets, V.S., Chelyadnikova, Y.A. et al. Effect of Large-Conductance Calcium-Dependent K+ Channel Activator NS1619 on Function of Mitochondria in the Heart of Dystrophin-Deficient Mice. Biochemistry Moscow 88, 189–201 (2023). https://doi.org/10.1134/S0006297923020037
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S0006297923020037